MedPath

Automated Cardiac Arrest Detection and Alerting in Daily Life

Not yet recruiting
Conditions
Cardiac Arrest (CA)
Sudden Death, Cardiac
Registration Number
NCT06692374
Lead Sponsor
Radboud University Medical Center
Brief Summary

Surviving a cardiac arrest that happens outside the hospital depends on quickly recognizing the event and immediately starting CPR. Survival rates have improved when cardiac arrest is witnessed, but when it isn't, help often arrives too late. Wearable biosensors, like special wristbands, could detect cardiac arrest automatically and alert emergency responders, providing faster help.

In the already finished DETECT-1 study, the investigators developed a system that uses wrist-worn sensors to identify cardiac arrest. The goal of the current study is to test how well this system works in people who have an implantable cardioverter defibrillator (ICD). An ICD is a device that monitors and treats dangerous heart rhythms. Study participants will wear a medical wristband with sensors that monitor the heartrate and movement during their daily activities to see if the system accurately detects cardiac arrest.

Detailed Description

Survival from out-of-hospital cardiac arrest (OHCA) depends on fast recognition of cardiac arrest and immediate initiation of cardiopulmonary resuscitation (CPR). While survival chances for witnessed OHCA have increased, unwitnessed cases still often receive help too late. Wearable biosensor technology with the functionality of automated cardiac arrest detection and activation of the emergency medical chain would offer a potential solution to provide early help. In the recently published DETECT-1 study, an algorithm for automated cardiac arrest detection using wrist-derived photoplethysmography (PPG) was recently developed.

The current study is a prospective multicenter observational cohort study to validate the sensitivity of the developed cardiac arrest detection algorithm in patients with an implantable cardioverter defibrillator (ICD) during daily life. The study population includes patients with an ICD. Study participants will wear a medical wristband with PPG and accelerometer sensors during daily life.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Patients with an implantable cardioverter defibrillator (ICD)
  • Age 18 years or older
  • Fitting the wristband
  • In possession of a smartphone that is compatible with the wristband
Exclusion Criteria
  • Known hemodynamically relevant bilateral subclavian artery stenosis
  • Medical issues that interfere with wearing of the wristband (e.g. skin disorders)
  • Insufficient skills to operate with the device/app

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sensitivity for cardiac arrest detectionFrom the time of enrollment to the end of the wearing period of the wristband (maximal two years)

The number of correctly identified cardiac arrest events by the algorithm devided by the total number of cardiac arrest events.

Secondary Outcome Measures
NameTimeMethod
Positive predictive value for cardiac arrest detectionFrom the time of enrollment to the end of the wearing period of the wristband (maximal two years)

The number of true positives devided by the sum of the true positives and false positive cardiac arrest alarms

False positive alarm rateFrom the time of enrollment to the end of the wearing period of the wristband (maximal two years)

Expressed as the number of false positive non-cancelled cardiac arrest alarms per user year

Trial Locations

Locations (1)

RadboudUMC

🇳🇱

Nijmegen, Gelderland, Netherlands

© Copyright 2025. All Rights Reserved by MedPath